| Issuer | % of Class | Filed |
|---|---|---|
|
Ernexa Therapeutics Inc.
13D/A
Amendment 8
ERNA · 114082308
|
34.7% |
2/17/2026
Event 2/10/2026
|
|
Ernexa Therapeutics Inc.
13D/A
Amendment 7
ERNA · 114082209
|
37.9% |
6/11/2025
Event 6/9/2025
|
|
Ernexa Therapeutics Inc.
13D/A
Amendment 6
ERNA · 114082209
|
32.8% |
4/4/2025
Event 4/2/2025
|
|
Eterna Therapeutics Inc.
13D/A
Amendment 5
ERNA · 114082209
|
32.4% |
3/5/2025
Event 10/29/2024
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.